Brimarafenib - CAS 1643326-82-2

Brimarafenib is a selective RAF dimerization inhibitor, which can inhibit the activity of BRAF and CRAF, and exhibits significant inhibitory effects on a variety of RAF mutations (including BRAF I/II/III mutations, BRAF fusion and CRAF heterodimerization), and is used for the treatment of colorectal and pancreatic cancers and other solid tumors with MAPK mutations.

Raf

MAPK

1643326-82-2

0.9832

C24H17F3N4O4

482.41

N(C(NC1=C(F)C=C(F)C(F)=C1)=O)[C@H]2[C@]3([C@@]2(OC=4C3=CC(OC5=C6C(NC=C5)=NC(=O)CC6)=CC4)[H])[H]

-20°C

Ice Packs

Small Compound